Asset Details
Do you wish to reserve the book?
Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro
Do you wish to request the book?
Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro
2016
Overview
Since cancer cells, when grown as spheroids, display drug sensitivity and radiation resistance patterns such as seen in vivo we recently established a three-dimensional (3D) in vitro model recapitulating colorectal cancer (CRC)-triggered lymphatic endothelial cell (LEC)-barrier breaching to study mechanisms of intra-/extravasation. CRC metastasizes not only through lymphatics but also through blood vessels and here we extend the 3D model to the interaction of blood endothelial cells (BECs) with naïve and 5-fluorouracil (5-FU)-resistant CRC CCL227 cells. The 3D model enabled quantifying effects of tumour-derived microRNA200 (miR200) miR200a, miR200b, miR200c, miR141 and miR429 regarding the induction of so-called 'circular chemorepellent-induced defects' (CCIDs) within the BEC-barrier, which resemble gates for tumour transmigration. For this, miR200 precursors were individually transfected and furthermore, the modulation of ZEB family expression was analysed by western blotting. miR200c, miR141 and miR429, which are contained in exosomes from naïve CCL227 cells, downregulated the expression of ZEB2, SNAI and TWIST in BECs. The exosomes of 5-FU-resistant CCL227-RH cells, which are devoid of miR200, accelerated CCID formation in BEC monolayers as compared to exosomes from naïve CCL227 cells. This confirmed the reported role of ZEB2 and SNAI in CRC metastasis and highlighted the active contribution of the stroma in the metastatic process. CCL227 spheroids affected the integrity of BEC and LEC barriers alike, which was in agreement with the observation that CRC metastasizes via blood stream (into the liver) as well as via lymphatics (into lymph nodes and lungs). This further validated the CRC/LEC and CRC/BEC in vitro model to study mechanisms of CRC spreading through vascular systems. Treatment of CCL227-RH cells with the HDAC inhibitors mocetinostat and sulforaphane reduced CCID formation to the level triggered by naïve CCL227 spheroids, however, without significantly influencing miR200 expression in CCL227-RH cells.
Publisher
D.A. Spandidos,Spandidos Publications,Spandidos Publications UK Ltd
Subject
Benzamides - administration & dosage
/ blood endothelial barrier breaching
/ Cell Movement - drug effects
/ Colorectal Neoplasms - genetics
/ Colorectal Neoplasms - pathology
/ Endothelial Cells - pathology
/ Endothelium, Vascular - metabolism
/ Endothelium, Vascular - pathology
/ exosomes
/ Gene Expression Regulation, Neoplastic - drug effects
/ Humans
/ Isothiocyanates - administration & dosage
/ Lymphatic Vessels - pathology
/ MicroRNA
/ Pyrimidines - administration & dosage
/ Spheroids, Cellular - drug effects
